T Cell Immunity to Lymphoma Following Treatment With Anti-Cd40 Monoclonal Antibody

Journal of Immunology- United States

doi 10.4049/jimmunol.168.6.2720

Full Text

Abstract

Available in

Date

Authors

Publisher

The American Association of Immunologists

Related search

Differential Reconstitution of T Cell Subsets Following Immunodepleting Treatment With Alemtuzumab (Anti-Cd52 Monoclonal Antibody) in Patients With Relapsing-Remitting Multiple Sclerosis

Journal of Immunology
AllergyImmunology
2013English

Preclinical Antilymphoma Activity of a Humanized Anti-Cd40 Monoclonal Antibody, SGN-40

Cancer Research
Cancer ResearchOncology
2005English

Development of a Chimeric Anti-Cd40 Monoclonal Antibody That Synergizes With LEA29Y to Prolong Islet Allograft Survival

Journal of Immunology
AllergyImmunology
2004English

Blockage of T Cell Activation via Anti-Cd40 and Anti-Cd154 Monoclonal Antibodies Can Possibility Treat Alopecia Areata

Scandinavian Journal of Immunology
MedicineImmunology
2016English

Anti-Ccr4 Monoclonal Antibody KW-0761 (Mogamulizumab) or Investigator's Choice in Subjects With Relapsed or Refractory Adult T-Cell Leukemia-Lymphoma (ATL)

Retrovirology
VirologyInfectious Diseases
2015English

Intensified and Protective CD4+T Cell Immunity in Mice With Anti–dendritic Cell HIV Gag Fusion Antibody Vaccine

Journal of Experimental Medicine
MedicineAllergyImmunology
2006English

Reproducing Indolent B-Cell Lymphoma Transformation With T-Cell Immunosuppression in LMP1/CD40-expressing Mice

Cellular and Molecular Immunology
Infectious DiseasesMedicineAllergyImmunology
2019English

Treatment of Atopic Dermatitis With Tralokinumab, an Anti–IL-13 Monoclonal Antibody

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Immunogenicity of Rat-Neu+ Mouse Mammary Tumours Determines the T Cell-Dependent Therapeutic Efficacy of Anti-Neu Monoclonal Antibody Treatment

Scientific Reports
Multidisciplinary
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy